IBB iShares Biotechnology ETF

67

NASDAQ | ETF

Price
$169.42
Decreased by -0.51%
Dollar volume (20D)
379.00 M
ADR%
1.72
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.

It is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
MORF Morphic Holding Inc Healthcare Biotechnology 1000.00%
VRTX Vertex Pharmaceuticals Inc Healthcare Biotechnology 7.40%
AMGN Amgen Inc Healthcare Drug Manufacturers - General 7.23%
GILD Gilead Sciences Inc Healthcare Drug Manufacturers - General 7.00%
REGN Regeneron Pharmaceuticals Inc Healthcare Biotechnology 6.08%
ALNY Alnylam Pharmaceuticals Inc Healthcare Biotechnology 4.48%
INSM Insmed Inc Healthcare Biotechnology 3.45%
ARGX argenx NV ADR Healthcare Biotechnology 3.25%
IQV IQVIA Holdings Inc Healthcare Diagnostics & Research 3.16%
NTRA Natera Inc Healthcare Diagnostics & Research 2.68%
MTD Mettler-Toledo International Inc Healthcare Diagnostics & Research 2.41%
BIIB Biogen Inc Healthcare Drug Manufacturers - General 2.21%
BNTX BioNTech SE Healthcare Biotechnology 2.06%
WAT Waters Corporation Healthcare Diagnostics & Research 1.97%
UTHR United Therapeutics Corporation Healthcare Drug Manufacturers - Specialty & Generic 1.79%
0ONC BEIGENE ADS REPRESENTING LTD 1.71%
ILMN Illumina Inc Healthcare Diagnostics & Research 1.70%
INCY Incyte Corporation Healthcare Biotechnology 1.58%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 1.49%
GMAB Genmab AS Healthcare Biotechnology 1.43%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY